CAI國際 CAI 深 滬
已收盤 04-02 16:00:00 美东时间
19.29
+0.160
+0.84%
華盛通- 最 高19.62
- 今 開18.61
- 成交量 154.16万股
- 最 低 17.99
- 昨 收 19.13
- 總市值 54.51亿
- 52周最高 42.50
- 市盈率 靜 --
- 換手率 0.55%
- 52周最低 16.28
- 委 比 -56.18%
- 總股本 2.83亿
- 歷史最高 42.50
- 量 比 0.60
- 振 幅 8.52%
- 歷史最低 16.28
- 每 手 1
- 風險率 5.24%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Is Caris Life Sciences Stock Gaining Wednesday?
Caris Life Sciences stock surges on positive Achieve 1 cancer test data. See key CAI levels and study results here.
04-01 22:03
Caris Life Sciences Finalizes Achieve 1 Study; Results Demonstrate The Superiority Of Whole Genome Sequencing Compared To Methylation-Based Approaches
Caris Life Sciences® (NASDAQ:CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the finalized Achieve 1 Study results. These results represent a
04-01 06:04
Caris Life Sciences Publishes Supporting Evidence For AI-Based Cancer Diagnosis
Caris Life Sciences published a study in JAMA Network Open, titled "An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins."
03-20 20:40
美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级
今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元
03-16 18:19
Caris Life Sciences Launches AI-Driven Pancreatic Cancer Signature To Guide First-Line Treatment In Pancreatic Ductal Adenocarcinoma
Caris AI Insights are proprietary and only available to Caris Life Sciences customersIRVING, Texas, March 9, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ:CAI), a leading patient-centric,
03-09 20:39
美股大行评级 | 下调居多！多邻国、Elastic、Flutter、欧特克、Zscaler等遭多家机构下调目标价
今日重点评级关注：巴克莱：维持C4 Therapeutics"超配"评级，目标价从5美元升至7美元；富国银行：维持Agilon Health"超配"评级，目标价从1美元升至1.5美元
03-02 14:08
/C O R R E C T I O N -- Caris Life Sciences/
In the news release, Caris Life Sciences Completes Interim Readout of Achieve 1 Study, issued 26-Feb-2026 by Caris Life Sciences over PR Newswire, we are advised by the company that PR Newsw...
02-27 07:59
Caris Life Sciences shares are trading higher after the company reported better-than-expected Q4 financial results.
Caris Life Sciences shares are trading higher after the company reported better...
02-27 05:47
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
